The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment

Thyroid ®,Volume 33, Issue 7, Page 835-848, July 2023.
Source: Thyroid - Category: Endocrinology Authors: Source Type: research